BDSX · Company research
Biodesix, Inc. Common Stock (BDSX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 27.96 | $299,613,600 | 269617600.0 | — | — | — | 11.1542235955474480 | 32.7661417322834646 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.